Sheriden K. Snedden
4 IP cases indexed. Covers patent matters.
Cases Presided Over
4 cases indexed | Page 1 of 1
Embody, Inc. et al. v.LifeNet Health
Embody and Zimmer Biomet successfully secured institution in this IPR against LifeNet Health's '223 patent. The Board found a reasonable likelihood that claims related to collagen scaffolds with specific FFT analysis characteristics are unpatentable over prior art references like Huang2 and Lee.
Embody, Inc. et al. v.LifeNet Health
Embody, Inc. challenged LifeNet Health's tissue engineering patent (11318227) based on anticipation and obviousness. The PTAB instituted trial on all eight claims after finding merit in the petitioner’s arguments regarding fiber alignment and FFT analysis.
AZURITY PHARMACEUTICALS, INC. v.Helsinn Healthcare S.A.
AZURITY PHARMACEUTICALS, INC. successfully secured institution of its IPR against Helsinn Healthcare S.A.'s patent (9186357) for anti-emetic agents. The Board found a reasonable likelihood that several claims would be unpatentable over prior art, specifically regarding the combination of triple-drug CINV treatment and superior NK antagonists.
AZURITY PHARMACEUTICALS, INC. v.Helsinn Healthcare S.A.
AZURITY PHARMACEUTICALS successfully convinced the PTAB to institute IPR proceedings against Helsinn Healthcare S.A.'s patent covering anti-emetic agents for oncology treatment. The Board found a reasonable likelihood that numerous claims would be unpatentable under 35 U.S.C. § 103 based on prior art references.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.